PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

Geoffrey T. Gibney; Jacob Zaemes; Shelly Shand; Neil J. Shah; David Swoboda; Kellie Gardner; Arash Radfar; Vesna Petronic-Rosic; Michael J. Reilly; Waddah B. Al-Refaie; Suthee Rapisuwon; Michael B. Atkins

doi:10.1136/jitc-2021-002955

Article info

PDF

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

Authors

Geoffrey T. Gibney Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USA PubMed articles Google scholar articles
Jacob Zaemes Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USA PubMed articles Google scholar articles
Shelly Shand Charleston Oncology, Charleston, South Carolina, USA PubMed articles Google scholar articles
Neil J. Shah Memorial Sloan Kettering Cancer Center, New York, New York, USA PubMed articles Google scholar articles
David Swoboda Moffitt Cancer Center, Tampa, Florida, USA PubMed articles Google scholar articles
Kellie Gardner MedStar Georgetown University Hospital, Washington, District of Columbia, USA PubMed articles Google scholar articles
Arash Radfar Inform Diagnostics, Irving, Texas, USA PubMed articles Google scholar articles
Vesna Petronic-Rosic Georgetown University Medical Center, Washington, District of Columbia, USA PubMed articles Google scholar articles
Michael J. Reilly MedStar Georgetown University Hospital, Washington, District of Columbia, USA PubMed articles Google scholar articles
Waddah B. Al-Refaie MedStar Georgetown University Hospital, Washington, District of Columbia, USA PubMed articles Google scholar articles
Suthee Rapisuwon Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USAMedStar Washington Hospital Center, Washington, District of Columbia, USA PubMed articles Google scholar articles
Michael B. Atkins Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USADepartment of Oncology, Georgetown University, Washington, District of Columbia, USA PubMed articles Google scholar articles

Citation

Gibney GT, Zaemes J, Shand S, et al

PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma

Journal for ImmunoTherapy of Cancer 2021;9:e002955. doi: 10.1136/jitc-2021-002955

Online issue publication

June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password